Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diet, Carbohydrate-Restricted | 28 | 2024 | 260 | 8.880 |
Why?
|
Dietary Carbohydrates | 40 | 2023 | 891 | 8.030 |
Why?
|
Obesity | 96 | 2024 | 12847 | 5.890 |
Why?
|
Glycemic Index | 30 | 2018 | 392 | 4.970 |
Why?
|
Diet, Fat-Restricted | 24 | 2024 | 328 | 4.820 |
Why?
|
Insulin | 34 | 2023 | 6571 | 3.740 |
Why?
|
Energy Metabolism | 21 | 2024 | 2860 | 3.730 |
Why?
|
Diet, Reducing | 15 | 2022 | 486 | 3.200 |
Why?
|
Overweight | 23 | 2024 | 2402 | 3.170 |
Why?
|
Dietary Fats | 19 | 2023 | 1987 | 3.150 |
Why?
|
Beverages | 15 | 2024 | 817 | 3.110 |
Why?
|
Energy Intake | 31 | 2024 | 2126 | 2.960 |
Why?
|
Carbohydrates | 13 | 2024 | 387 | 2.800 |
Why?
|
Weight Loss | 25 | 2024 | 2669 | 2.640 |
Why?
|
Diet | 39 | 2023 | 7965 | 2.410 |
Why?
|
Sweetening Agents | 8 | 2024 | 290 | 2.250 |
Why?
|
Dietary Sucrose | 9 | 2013 | 245 | 2.080 |
Why?
|
Weight Gain | 16 | 2023 | 2333 | 1.970 |
Why?
|
Insulin Resistance | 19 | 2023 | 3946 | 1.890 |
Why?
|
Milk | 5 | 2020 | 443 | 1.810 |
Why?
|
Blood Glucose | 32 | 2023 | 6350 | 1.710 |
Why?
|
Nutrition Policy | 9 | 2020 | 473 | 1.670 |
Why?
|
Body Composition | 18 | 2024 | 2415 | 1.660 |
Why?
|
Body Weight | 22 | 2021 | 4608 | 1.610 |
Why?
|
Feeding Behavior | 14 | 2022 | 3180 | 1.310 |
Why?
|
Food Industry | 4 | 2018 | 67 | 1.250 |
Why?
|
Hyperinsulinism | 3 | 2022 | 397 | 1.250 |
Why?
|
Food | 9 | 2018 | 776 | 1.250 |
Why?
|
Taxes | 4 | 2015 | 221 | 1.200 |
Why?
|
Adipose Tissue | 7 | 2024 | 3289 | 1.050 |
Why?
|
Nutritional Requirements | 3 | 2020 | 275 | 1.030 |
Why?
|
Postprandial Period | 7 | 2013 | 310 | 0.990 |
Why?
|
Science | 2 | 2019 | 239 | 0.930 |
Why?
|
Guidelines as Topic | 6 | 2020 | 1392 | 0.890 |
Why?
|
Public Health | 12 | 2018 | 2658 | 0.880 |
Why?
|
Chronic Disease | 8 | 2021 | 9202 | 0.870 |
Why?
|
Hyperphagia | 3 | 2023 | 136 | 0.860 |
Why?
|
Body Mass Index | 29 | 2023 | 12844 | 0.830 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2021 | 3398 | 0.830 |
Why?
|
Legislation as Topic | 2 | 2013 | 77 | 0.810 |
Why?
|
Humans | 196 | 2024 | 756111 | 0.800 |
Why?
|
Food Technology | 2 | 2011 | 6 | 0.750 |
Why?
|
Diabetes Mellitus, Type 2 | 19 | 2021 | 12203 | 0.740 |
Why?
|
Nutritive Value | 6 | 2013 | 348 | 0.730 |
Why?
|
Caloric Restriction | 2 | 2018 | 290 | 0.730 |
Why?
|
Nutritional Status | 4 | 2022 | 1600 | 0.720 |
Why?
|
Nutritional Sciences | 4 | 2020 | 137 | 0.720 |
Why?
|
Food Labeling | 3 | 2017 | 181 | 0.680 |
Why?
|
Restaurants | 3 | 2009 | 231 | 0.660 |
Why?
|
Taste | 1 | 2020 | 186 | 0.650 |
Why?
|
Triglycerides | 9 | 2024 | 2472 | 0.650 |
Why?
|
Water | 3 | 2021 | 1394 | 0.640 |
Why?
|
Clinical Trials as Topic | 6 | 2022 | 8014 | 0.590 |
Why?
|
Cholesterol, HDL | 6 | 2024 | 1811 | 0.590 |
Why?
|
Fatty Liver | 4 | 2013 | 764 | 0.580 |
Why?
|
Clinical Medicine | 2 | 2008 | 145 | 0.570 |
Why?
|
Adiposity | 5 | 2020 | 1846 | 0.570 |
Why?
|
Pharmaceutical Preparations | 2 | 2019 | 1088 | 0.560 |
Why?
|
Health Behavior | 5 | 2015 | 2619 | 0.550 |
Why?
|
Hunger | 6 | 2017 | 206 | 0.540 |
Why?
|
Child | 52 | 2023 | 79418 | 0.530 |
Why?
|
Child Behavior | 4 | 2016 | 845 | 0.530 |
Why?
|
Adolescent | 56 | 2024 | 87297 | 0.510 |
Why?
|
Reaction Time | 1 | 2021 | 2077 | 0.500 |
Why?
|
Environment | 2 | 2018 | 1116 | 0.490 |
Why?
|
Child Welfare | 4 | 2012 | 524 | 0.480 |
Why?
|
Lipids | 5 | 2017 | 3334 | 0.480 |
Why?
|
Food Supply | 4 | 2020 | 522 | 0.470 |
Why?
|
Research | 2 | 2020 | 1968 | 0.470 |
Why?
|
Appetite Regulation | 2 | 2007 | 84 | 0.470 |
Why?
|
Hysteria | 1 | 2013 | 20 | 0.460 |
Why?
|
Dyslipidemias | 1 | 2022 | 892 | 0.460 |
Why?
|
Adult | 62 | 2024 | 218302 | 0.460 |
Why?
|
Life Style | 7 | 2018 | 3864 | 0.460 |
Why?
|
Obesity, Morbid | 2 | 2018 | 1269 | 0.460 |
Why?
|
Cross-Over Studies | 9 | 2017 | 2051 | 0.450 |
Why?
|
Body Water | 1 | 2015 | 335 | 0.450 |
Why?
|
Philosophy | 1 | 2013 | 68 | 0.450 |
Why?
|
Nutrition Assessment | 1 | 2017 | 721 | 0.440 |
Why?
|
Conflict of Interest | 1 | 2018 | 548 | 0.440 |
Why?
|
Television | 4 | 2015 | 408 | 0.420 |
Why?
|
Metabolome | 2 | 2017 | 969 | 0.420 |
Why?
|
Hypothalamus | 5 | 2021 | 997 | 0.410 |
Why?
|
Disclosure | 1 | 2018 | 738 | 0.410 |
Why?
|
Female | 85 | 2024 | 388229 | 0.410 |
Why?
|
Male | 84 | 2024 | 356852 | 0.410 |
Why?
|
Publishing | 1 | 2019 | 835 | 0.410 |
Why?
|
Rest | 2 | 2015 | 916 | 0.400 |
Why?
|
Emigrants and Immigrants | 1 | 2018 | 535 | 0.400 |
Why?
|
Reward | 2 | 2021 | 952 | 0.390 |
Why?
|
Biology | 1 | 2013 | 289 | 0.380 |
Why?
|
Hypothalamic Hormones | 4 | 2001 | 145 | 0.380 |
Why?
|
Pituitary Hormones | 4 | 2001 | 183 | 0.380 |
Why?
|
Appetite | 1 | 2013 | 247 | 0.380 |
Why?
|
Fructose | 1 | 2013 | 287 | 0.380 |
Why?
|
Eating | 5 | 2019 | 1538 | 0.370 |
Why?
|
Malnutrition | 3 | 2012 | 634 | 0.370 |
Why?
|
Social Welfare | 1 | 2011 | 87 | 0.360 |
Why?
|
United States | 34 | 2024 | 71909 | 0.360 |
Why?
|
Hyperglycemia | 4 | 2021 | 1372 | 0.360 |
Why?
|
Heart Diseases | 4 | 2013 | 2799 | 0.360 |
Why?
|
Exercise | 7 | 2017 | 5758 | 0.350 |
Why?
|
Absorptiometry, Photon | 2 | 2023 | 1719 | 0.350 |
Why?
|
Food Packaging | 1 | 2010 | 13 | 0.350 |
Why?
|
Dietary Fiber | 3 | 2013 | 758 | 0.350 |
Why?
|
Melanins | 4 | 2001 | 291 | 0.350 |
Why?
|
Longevity | 2 | 2016 | 1037 | 0.350 |
Why?
|
Parent-Child Relations | 2 | 2012 | 756 | 0.340 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1490 | 0.340 |
Why?
|
Cholera Toxin | 7 | 1989 | 558 | 0.330 |
Why?
|
Cooking | 2 | 2015 | 311 | 0.330 |
Why?
|
Young Adult | 20 | 2024 | 58143 | 0.320 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1456 | 0.310 |
Why?
|
Models, Psychological | 2 | 2016 | 826 | 0.310 |
Why?
|
State Government | 1 | 2011 | 381 | 0.310 |
Why?
|
Glucose | 5 | 2018 | 4352 | 0.310 |
Why?
|
Life Expectancy | 2 | 2005 | 1248 | 0.300 |
Why?
|
Research Design | 4 | 2024 | 6143 | 0.300 |
Why?
|
Inpatients | 1 | 2019 | 2579 | 0.290 |
Why?
|
Satiation | 3 | 2003 | 83 | 0.280 |
Why?
|
Education | 1 | 2010 | 536 | 0.280 |
Why?
|
Adaptation, Physiological | 3 | 2023 | 1289 | 0.280 |
Why?
|
Pandemics | 4 | 2023 | 8570 | 0.280 |
Why?
|
Child Nutrition Disorders | 1 | 2008 | 148 | 0.280 |
Why?
|
Calcium | 1 | 2020 | 5704 | 0.280 |
Why?
|
Violence | 1 | 2013 | 926 | 0.270 |
Why?
|
Waist-Hip Ratio | 1 | 2008 | 516 | 0.270 |
Why?
|
Health Promotion | 3 | 2013 | 2208 | 0.270 |
Why?
|
Cardiovascular Diseases | 9 | 2024 | 15659 | 0.260 |
Why?
|
Biodiversity | 1 | 2008 | 345 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.250 |
Why?
|
Bariatric Surgery | 2 | 2012 | 984 | 0.250 |
Why?
|
Birth Weight | 2 | 2010 | 2076 | 0.250 |
Why?
|
Meditation | 1 | 2008 | 249 | 0.250 |
Why?
|
Firearms | 1 | 2013 | 625 | 0.250 |
Why?
|
Registries | 2 | 2019 | 8402 | 0.250 |
Why?
|
C-Reactive Protein | 3 | 2020 | 3812 | 0.240 |
Why?
|
Child Development | 2 | 2013 | 2269 | 0.240 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2005 | 125 | 0.240 |
Why?
|
Health Education | 2 | 2010 | 1050 | 0.240 |
Why?
|
Counseling | 4 | 2017 | 1549 | 0.240 |
Why?
|
Head | 1 | 2010 | 920 | 0.240 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 453 | 0.240 |
Why?
|
Vegetables | 2 | 2023 | 1195 | 0.240 |
Why?
|
Carbonated Beverages | 2 | 2007 | 209 | 0.230 |
Why?
|
Practice Guidelines as Topic | 5 | 2013 | 7439 | 0.230 |
Why?
|
Peer Review, Research | 1 | 2007 | 341 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 415 | 0.220 |
Why?
|
Deuterium | 2 | 2021 | 101 | 0.220 |
Why?
|
Cholesterol, LDL | 2 | 2024 | 2416 | 0.220 |
Why?
|
Motor Activity | 3 | 2010 | 2688 | 0.210 |
Why?
|
Health Policy | 3 | 2010 | 2666 | 0.210 |
Why?
|
Intention to Treat Analysis | 2 | 2022 | 419 | 0.210 |
Why?
|
Research Support as Topic | 1 | 2007 | 700 | 0.200 |
Why?
|
Pilot Projects | 6 | 2016 | 8498 | 0.200 |
Why?
|
Risk Factors | 19 | 2020 | 73898 | 0.200 |
Why?
|
Cholesterol | 3 | 2024 | 2923 | 0.200 |
Why?
|
United States Department of Agriculture | 2 | 2011 | 47 | 0.200 |
Why?
|
Glucose Tolerance Test | 4 | 2008 | 1173 | 0.200 |
Why?
|
Fisheries | 1 | 2022 | 45 | 0.200 |
Why?
|
Medicine | 1 | 2010 | 936 | 0.190 |
Why?
|
Hypercholesterolemia | 1 | 2008 | 1155 | 0.190 |
Why?
|
Antioxidants | 1 | 2009 | 1653 | 0.190 |
Why?
|
Oxygen Isotopes | 1 | 2021 | 44 | 0.190 |
Why?
|
Anticholesteremic Agents | 1 | 2008 | 987 | 0.190 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2471 | 0.190 |
Why?
|
alpha-MSH | 2 | 1998 | 72 | 0.190 |
Why?
|
Risk Reduction Behavior | 1 | 2007 | 1098 | 0.190 |
Why?
|
Education, Medical | 2 | 2010 | 1721 | 0.190 |
Why?
|
Area Under Curve | 3 | 2013 | 1629 | 0.180 |
Why?
|
Liver | 3 | 2013 | 7475 | 0.180 |
Why?
|
Dairy Products | 2 | 2015 | 495 | 0.180 |
Why?
|
Patient Compliance | 3 | 2017 | 2683 | 0.180 |
Why?
|
Nutritional Physiological Phenomena | 3 | 2009 | 363 | 0.180 |
Why?
|
Lactose Intolerance | 1 | 2020 | 28 | 0.180 |
Why?
|
Serial Publications | 1 | 2020 | 11 | 0.180 |
Why?
|
Animals | 20 | 2024 | 167069 | 0.180 |
Why?
|
Endocrine Disruptors | 1 | 2023 | 262 | 0.170 |
Why?
|
Pregnancy Complications | 2 | 2010 | 2923 | 0.170 |
Why?
|
Massachusetts | 4 | 2017 | 8733 | 0.170 |
Why?
|
Satiety Response | 2 | 2011 | 47 | 0.170 |
Why?
|
Middle Aged | 22 | 2024 | 218357 | 0.160 |
Why?
|
Diabetes Mellitus | 4 | 2018 | 5846 | 0.160 |
Why?
|
Pediatrics | 4 | 2008 | 3582 | 0.160 |
Why?
|
Obesity, Abdominal | 2 | 2020 | 374 | 0.160 |
Why?
|
Homeostasis | 4 | 2018 | 3284 | 0.160 |
Why?
|
Catheterization, Peripheral | 1 | 2002 | 341 | 0.160 |
Why?
|
Fruit | 2 | 2015 | 1159 | 0.160 |
Why?
|
Literature, Modern | 1 | 2018 | 30 | 0.160 |
Why?
|
Social Justice | 1 | 2023 | 473 | 0.160 |
Why?
|
Disease Management | 1 | 2009 | 2484 | 0.150 |
Why?
|
G(M1) Ganglioside | 4 | 1988 | 87 | 0.150 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2214 | 0.150 |
Why?
|
Students, Medical | 1 | 2011 | 1891 | 0.150 |
Why?
|
Oxidative Stress | 1 | 2009 | 3065 | 0.150 |
Why?
|
Disease Outbreaks | 4 | 2009 | 1746 | 0.150 |
Why?
|
Evidence-Based Medicine | 3 | 2016 | 3686 | 0.150 |
Why?
|
Curriculum | 1 | 2011 | 3676 | 0.150 |
Why?
|
Causality | 1 | 2024 | 1237 | 0.150 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2686 | 0.150 |
Why?
|
Choice Behavior | 2 | 2014 | 812 | 0.150 |
Why?
|
Triage | 2 | 2020 | 982 | 0.150 |
Why?
|
Social Support | 1 | 2007 | 2134 | 0.150 |
Why?
|
Carbohydrate Metabolism | 1 | 2018 | 258 | 0.150 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2005 | 1917 | 0.150 |
Why?
|
Leptin | 5 | 2012 | 1592 | 0.150 |
Why?
|
World Health Organization | 1 | 2023 | 1309 | 0.150 |
Why?
|
Treatment Outcome | 12 | 2022 | 64582 | 0.140 |
Why?
|
Body Weights and Measures | 1 | 2017 | 208 | 0.140 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1646 | 0.140 |
Why?
|
Hand | 1 | 2002 | 893 | 0.140 |
Why?
|
Glycerides | 1 | 2017 | 68 | 0.140 |
Why?
|
Guideline Adherence | 1 | 2007 | 2280 | 0.140 |
Why?
|
Anthropometry | 4 | 2007 | 1342 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 3947 | 0.140 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 1996 | 37 | 0.130 |
Why?
|
Hypoglycemic Agents | 3 | 2018 | 3120 | 0.130 |
Why?
|
Lipid Metabolism | 1 | 2004 | 1896 | 0.130 |
Why?
|
Social Responsibility | 2 | 2008 | 385 | 0.130 |
Why?
|
Forecasting | 1 | 2005 | 2928 | 0.130 |
Why?
|
Enterotoxins | 2 | 1987 | 367 | 0.130 |
Why?
|
Respiration | 1 | 2022 | 1647 | 0.130 |
Why?
|
Sodium Benzoate | 1 | 2014 | 15 | 0.120 |
Why?
|
Recreation | 1 | 2015 | 120 | 0.120 |
Why?
|
Cholesterol, Dietary | 1 | 2015 | 225 | 0.120 |
Why?
|
Hydrocortisone | 2 | 2013 | 1802 | 0.120 |
Why?
|
Models, Biological | 3 | 2022 | 9453 | 0.120 |
Why?
|
Dietary Proteins | 2 | 2015 | 938 | 0.120 |
Why?
|
Elementary Particles | 1 | 2014 | 52 | 0.120 |
Why?
|
Quantum Theory | 1 | 2014 | 68 | 0.110 |
Why?
|
Sex Factors | 3 | 2017 | 10491 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2017 | 10256 | 0.110 |
Why?
|
Adolescent Behavior | 4 | 2016 | 1182 | 0.110 |
Why?
|
Mortality | 1 | 2005 | 2901 | 0.110 |
Why?
|
Reference Values | 2 | 2015 | 4919 | 0.110 |
Why?
|
C-Peptide | 1 | 2015 | 433 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2018 | 640 | 0.110 |
Why?
|
Age Factors | 5 | 2017 | 18372 | 0.110 |
Why?
|
Blood Pressure | 5 | 2017 | 8500 | 0.110 |
Why?
|
Physicians | 1 | 2011 | 4561 | 0.110 |
Why?
|
Body Height | 1 | 2020 | 1564 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3323 | 0.110 |
Why?
|
Attitude to Health | 3 | 2012 | 2030 | 0.110 |
Why?
|
Primary Health Care | 3 | 2016 | 4635 | 0.110 |
Why?
|
Coronary Disease | 1 | 2007 | 5994 | 0.110 |
Why?
|
Receptors, Cell Surface | 3 | 1987 | 2820 | 0.110 |
Why?
|
Epitopes | 4 | 1987 | 2502 | 0.100 |
Why?
|
Incidence | 5 | 2020 | 21259 | 0.100 |
Why?
|
Connecticut | 1 | 2013 | 366 | 0.100 |
Why?
|
Atherosclerosis | 1 | 2008 | 3514 | 0.100 |
Why?
|
Enteral Nutrition | 1 | 2018 | 779 | 0.100 |
Why?
|
Boston | 5 | 2017 | 9259 | 0.100 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 979 | 0.100 |
Why?
|
Time Factors | 6 | 2022 | 39991 | 0.100 |
Why?
|
Food Hypersensitivity | 1 | 2020 | 692 | 0.100 |
Why?
|
Epidemics | 1 | 2018 | 510 | 0.100 |
Why?
|
Aged | 14 | 2022 | 167585 | 0.100 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3836 | 0.100 |
Why?
|
Child, Preschool | 8 | 2016 | 41848 | 0.100 |
Why?
|
Family Practice | 2 | 2007 | 507 | 0.100 |
Why?
|
Books | 1 | 2011 | 22 | 0.100 |
Why?
|
Harm Reduction | 1 | 2013 | 141 | 0.100 |
Why?
|
Community Health Services | 1 | 2016 | 655 | 0.100 |
Why?
|
Receptors, Immunologic | 3 | 1987 | 1427 | 0.100 |
Why?
|
Poisoning | 1 | 2013 | 251 | 0.100 |
Why?
|
Interleukin-6 | 2 | 2020 | 3203 | 0.090 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2012 | 279 | 0.090 |
Why?
|
Fasting | 4 | 2018 | 1595 | 0.090 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 374 | 0.090 |
Why?
|
Cross Infection | 1 | 2020 | 1428 | 0.090 |
Why?
|
Financing, Government | 1 | 2014 | 470 | 0.090 |
Why?
|
Pregnancy | 5 | 2013 | 29548 | 0.090 |
Why?
|
Amino Acids | 1 | 2017 | 1715 | 0.090 |
Why?
|
Cadaver | 1 | 2015 | 1342 | 0.090 |
Why?
|
Diet, Protein-Restricted | 1 | 2010 | 71 | 0.090 |
Why?
|
Alanine Transaminase | 1 | 2013 | 605 | 0.090 |
Why?
|
History, 20th Century | 1 | 2018 | 2760 | 0.090 |
Why?
|
Escherichia coli Proteins | 2 | 1987 | 1059 | 0.090 |
Why?
|
Foster Home Care | 1 | 2011 | 132 | 0.090 |
Why?
|
Ownership | 1 | 2013 | 334 | 0.090 |
Why?
|
Diet Records | 1 | 2011 | 424 | 0.090 |
Why?
|
Mass Screening | 1 | 2006 | 5411 | 0.090 |
Why?
|
Homicide | 1 | 2013 | 295 | 0.090 |
Why?
|
Inflammation Mediators | 2 | 2017 | 1875 | 0.090 |
Why?
|
F2-Isoprostanes | 1 | 2009 | 35 | 0.090 |
Why?
|
Child Nutrition Sciences | 1 | 2009 | 22 | 0.080 |
Why?
|
Fetal Macrosomia | 1 | 2010 | 128 | 0.080 |
Why?
|
Internship and Residency | 1 | 2010 | 5832 | 0.080 |
Why?
|
Epinephrine | 1 | 2013 | 789 | 0.080 |
Why?
|
Dancing | 1 | 2010 | 102 | 0.080 |
Why?
|
Economics | 1 | 2010 | 141 | 0.080 |
Why?
|
Industry | 1 | 2011 | 360 | 0.080 |
Why?
|
Adolescent Development | 1 | 2012 | 281 | 0.080 |
Why?
|
Health Care Surveys | 2 | 2007 | 2430 | 0.080 |
Why?
|
Antibodies, Monoclonal | 6 | 2005 | 9113 | 0.080 |
Why?
|
Environmental Pollutants | 1 | 2018 | 1241 | 0.080 |
Why?
|
Anion Exchange Resins | 1 | 2008 | 10 | 0.080 |
Why?
|
New York | 1 | 2011 | 877 | 0.080 |
Why?
|
Evidence-Based Practice | 1 | 2013 | 493 | 0.080 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11881 | 0.080 |
Why?
|
Prevalence | 3 | 2018 | 15599 | 0.080 |
Why?
|
Waste Management | 1 | 2008 | 19 | 0.080 |
Why?
|
Genotype | 1 | 2023 | 12876 | 0.080 |
Why?
|
Lobbying | 1 | 2008 | 32 | 0.080 |
Why?
|
Mitochondria | 1 | 2022 | 3575 | 0.080 |
Why?
|
Biomedical Research | 2 | 2018 | 3390 | 0.080 |
Why?
|
Public Policy | 1 | 2013 | 559 | 0.080 |
Why?
|
Random Allocation | 1 | 2013 | 2389 | 0.080 |
Why?
|
Environmental Exposure | 1 | 2023 | 4357 | 0.080 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39187 | 0.080 |
Why?
|
Health Care Costs | 2 | 2016 | 3230 | 0.080 |
Why?
|
Health Status | 2 | 2012 | 4057 | 0.080 |
Why?
|
Quebec | 1 | 2008 | 141 | 0.080 |
Why?
|
Intra-Abdominal Fat | 1 | 2013 | 606 | 0.080 |
Why?
|
Chile | 1 | 2008 | 246 | 0.070 |
Why?
|
Food Preferences | 1 | 2011 | 398 | 0.070 |
Why?
|
Hormones | 2 | 2002 | 871 | 0.070 |
Why?
|
Fractures, Bone | 1 | 2020 | 2025 | 0.070 |
Why?
|
Deltaretrovirus | 1 | 1987 | 161 | 0.070 |
Why?
|
Personal Autonomy | 1 | 2010 | 300 | 0.070 |
Why?
|
Metabolomics | 1 | 2017 | 1613 | 0.070 |
Why?
|
Animal Feed | 1 | 2007 | 112 | 0.070 |
Why?
|
Risk Assessment | 4 | 2012 | 23956 | 0.070 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1989 | 354 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25715 | 0.070 |
Why?
|
Data Collection | 2 | 2011 | 3306 | 0.070 |
Why?
|
Prejudice | 1 | 2011 | 564 | 0.070 |
Why?
|
Immunoglobulin Idiotypes | 1 | 1987 | 200 | 0.070 |
Why?
|
Accidents, Traffic | 1 | 2013 | 816 | 0.070 |
Why?
|
Health Planning Guidelines | 1 | 2007 | 150 | 0.070 |
Why?
|
Mental Disorders | 1 | 2007 | 6794 | 0.070 |
Why?
|
Mice | 8 | 2020 | 80709 | 0.070 |
Why?
|
Preventive Medicine | 1 | 2008 | 252 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2012 | 822 | 0.070 |
Why?
|
Single-Blind Method | 1 | 2010 | 1575 | 0.070 |
Why?
|
Health Care Sector | 1 | 2008 | 196 | 0.070 |
Why?
|
Societies, Medical | 2 | 2009 | 3858 | 0.070 |
Why?
|
Pulmonary Gas Exchange | 1 | 2008 | 378 | 0.070 |
Why?
|
Research Personnel | 1 | 2011 | 580 | 0.070 |
Why?
|
Conservation of Natural Resources | 1 | 2008 | 205 | 0.070 |
Why?
|
Brain | 1 | 2013 | 26883 | 0.070 |
Why?
|
Costs and Cost Analysis | 2 | 2013 | 1674 | 0.070 |
Why?
|
Odds Ratio | 2 | 2010 | 9719 | 0.070 |
Why?
|
Siblings | 1 | 2010 | 825 | 0.070 |
Why?
|
Commerce | 1 | 2011 | 601 | 0.070 |
Why?
|
Behavior Therapy | 1 | 2012 | 859 | 0.070 |
Why?
|
Diet Therapy | 1 | 2007 | 151 | 0.070 |
Why?
|
Mice, Inbred Strains | 1 | 2008 | 1759 | 0.060 |
Why?
|
Pulse | 1 | 2005 | 218 | 0.060 |
Why?
|
Cause of Death | 1 | 2016 | 3710 | 0.060 |
Why?
|
Insulin, Long-Acting | 1 | 2005 | 58 | 0.060 |
Why?
|
Critical Illness | 1 | 2018 | 2696 | 0.060 |
Why?
|
Prediabetic State | 1 | 2011 | 541 | 0.060 |
Why?
|
Cohort Studies | 6 | 2020 | 41121 | 0.060 |
Why?
|
Diet Surveys | 2 | 2011 | 1160 | 0.060 |
Why?
|
Stress, Psychological | 2 | 2012 | 4386 | 0.060 |
Why?
|
Diabetic Nephropathies | 1 | 2012 | 978 | 0.060 |
Why?
|
Proteins | 3 | 2004 | 6026 | 0.060 |
Why?
|
Prospective Studies | 9 | 2024 | 54040 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3213 | 0.060 |
Why?
|
Quality of Life | 3 | 2012 | 13215 | 0.060 |
Why?
|
Hypertension | 4 | 2020 | 8532 | 0.060 |
Why?
|
Bacterial Toxins | 2 | 1987 | 930 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2010 | 26034 | 0.060 |
Why?
|
Adolescent Medicine | 1 | 2005 | 73 | 0.060 |
Why?
|
Promoter Regions, Genetic | 1 | 1996 | 5787 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6244 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2007 | 749 | 0.060 |
Why?
|
Nurse Practitioners | 1 | 2007 | 266 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20002 | 0.060 |
Why?
|
Radial Artery | 1 | 2005 | 197 | 0.060 |
Why?
|
Biological Availability | 1 | 2004 | 396 | 0.060 |
Why?
|
Diabetes, Gestational | 1 | 2013 | 1237 | 0.060 |
Why?
|
Receptors, Virus | 1 | 1987 | 638 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2004 | 401 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2011 | 12160 | 0.050 |
Why?
|
Hepacivirus | 1 | 2010 | 1333 | 0.050 |
Why?
|
Cyclophosphamide | 1 | 2009 | 2218 | 0.050 |
Why?
|
Kidney Failure, Chronic | 2 | 2012 | 2425 | 0.050 |
Why?
|
Telemedicine | 2 | 2016 | 2986 | 0.050 |
Why?
|
Crohn Disease | 2 | 2009 | 2267 | 0.050 |
Why?
|
Hepatitis C, Chronic | 1 | 2010 | 1028 | 0.050 |
Why?
|
Feces | 1 | 2008 | 1450 | 0.050 |
Why?
|
Hospitalization | 2 | 2020 | 10683 | 0.050 |
Why?
|
District of Columbia | 2 | 2012 | 159 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2014 | 3561 | 0.050 |
Why?
|
Viral Vaccines | 1 | 1987 | 597 | 0.050 |
Why?
|
Digestion | 1 | 2001 | 54 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2003 | 183 | 0.050 |
Why?
|
Gestational Age | 1 | 2010 | 3557 | 0.050 |
Why?
|
Regression Analysis | 2 | 2003 | 6362 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2010 | 1668 | 0.050 |
Why?
|
Vibrio cholerae | 1 | 1987 | 797 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2023 | 79746 | 0.050 |
Why?
|
Self Concept | 1 | 2007 | 1031 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2007 | 3471 | 0.050 |
Why?
|
Calorimetry, Indirect | 1 | 2021 | 174 | 0.050 |
Why?
|
Knowledge | 1 | 2022 | 176 | 0.040 |
Why?
|
London | 1 | 2020 | 234 | 0.040 |
Why?
|
Logistic Models | 2 | 2007 | 13316 | 0.040 |
Why?
|
Glucagon | 3 | 2014 | 527 | 0.040 |
Why?
|
Pancreatectomy | 1 | 2004 | 809 | 0.040 |
Why?
|
Schools | 1 | 2008 | 1464 | 0.040 |
Why?
|
Digestive System Surgical Procedures | 1 | 2005 | 577 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 412 | 0.040 |
Why?
|
Amino Acid Sequence | 7 | 1996 | 13425 | 0.040 |
Why?
|
Antibodies | 1 | 1987 | 2414 | 0.040 |
Why?
|
Liver Diseases | 1 | 2007 | 1283 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2011 | 3998 | 0.040 |
Why?
|
Electric Impedance | 1 | 2023 | 741 | 0.040 |
Why?
|
Neurotensin | 1 | 1998 | 57 | 0.040 |
Why?
|
Receptors, Melanocortin | 1 | 1998 | 24 | 0.040 |
Why?
|
Nitrogen | 1 | 2000 | 350 | 0.040 |
Why?
|
Receptors, Corticotropin | 1 | 1998 | 24 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1987 | 2196 | 0.040 |
Why?
|
Adiponectin | 1 | 2004 | 1113 | 0.040 |
Why?
|
Escherichia coli | 2 | 1987 | 4210 | 0.040 |
Why?
|
Veins | 1 | 2002 | 765 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2004 | 1327 | 0.040 |
Why?
|
Brazil | 1 | 2022 | 1195 | 0.040 |
Why?
|
Infant | 2 | 2013 | 35828 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2005 | 1341 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2005 | 1617 | 0.040 |
Why?
|
Brain Mapping | 1 | 2013 | 6605 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2010 | 3044 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 13940 | 0.040 |
Why?
|
Neuropeptide Y | 1 | 1998 | 191 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2008 | 2610 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2007 | 1264 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2009 | 15228 | 0.040 |
Why?
|
Molecular Sequence Data | 5 | 1996 | 17607 | 0.040 |
Why?
|
Parents | 1 | 2011 | 3532 | 0.040 |
Why?
|
Leukemia | 1 | 2005 | 1510 | 0.040 |
Why?
|
Rats, Inbred Strains | 1 | 1998 | 2082 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2007 | 6018 | 0.030 |
Why?
|
Rats | 3 | 2004 | 23564 | 0.030 |
Why?
|
Communicable Diseases | 1 | 2005 | 878 | 0.030 |
Why?
|
Neoplasms | 1 | 2005 | 21899 | 0.030 |
Why?
|
Antigen-Antibody Complex | 2 | 1989 | 512 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4093 | 0.030 |
Why?
|
Antibody Specificity | 2 | 1989 | 1061 | 0.030 |
Why?
|
Sleep | 1 | 2012 | 4717 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2004 | 21780 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2004 | 8159 | 0.030 |
Why?
|
Risk | 2 | 2011 | 9626 | 0.030 |
Why?
|
Cross Reactions | 2 | 1987 | 814 | 0.030 |
Why?
|
Hippurates | 1 | 2014 | 16 | 0.030 |
Why?
|
Food Preservatives | 1 | 2014 | 11 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1163 | 0.030 |
Why?
|
Editorial Policies | 1 | 2020 | 456 | 0.030 |
Why?
|
Gluconeogenesis | 1 | 1996 | 182 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2002 | 875 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3443 | 0.030 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2016 | 295 | 0.030 |
Why?
|
Mesons | 1 | 2014 | 31 | 0.030 |
Why?
|
Patient Dropouts | 1 | 2016 | 411 | 0.030 |
Why?
|
Thermogenesis | 1 | 2018 | 468 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1998 | 701 | 0.030 |
Why?
|
Linear Models | 1 | 2003 | 5864 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2008 | 4364 | 0.030 |
Why?
|
Telephone | 1 | 2016 | 621 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4489 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2005 | 2445 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 264 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 1999 | 1600 | 0.030 |
Why?
|
Food Handling | 1 | 2013 | 153 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3061 | 0.030 |
Why?
|
Meat | 1 | 2015 | 584 | 0.020 |
Why?
|
HLA Antigens | 2 | 1987 | 1355 | 0.020 |
Why?
|
Trans Fatty Acids | 1 | 2013 | 155 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12950 | 0.020 |
Why?
|
Glycine | 1 | 2014 | 662 | 0.020 |
Why?
|
Models, Statistical | 2 | 2010 | 5062 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 935 | 0.020 |
Why?
|
Base Sequence | 3 | 1996 | 12439 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 1987 | 1757 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1987 | 3785 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 16442 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2004 | 7786 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17684 | 0.020 |
Why?
|
Pulse Therapy, Drug | 1 | 2009 | 36 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2909 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2608 | 0.020 |
Why?
|
Waist Circumference | 1 | 2012 | 921 | 0.020 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2010 | 208 | 0.020 |
Why?
|
Models, Structural | 1 | 1989 | 341 | 0.020 |
Why?
|
Markov Chains | 1 | 2012 | 973 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2001 | 9479 | 0.020 |
Why?
|
Macromolecular Substances | 2 | 1988 | 1432 | 0.020 |
Why?
|
Drinking | 1 | 2009 | 199 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1999 | 3003 | 0.020 |
Why?
|
Peptide Fragments | 2 | 1998 | 5085 | 0.020 |
Why?
|
Chimera | 1 | 1989 | 450 | 0.020 |
Why?
|
Injections, Intraventricular | 2 | 1998 | 225 | 0.020 |
Why?
|
Blindness | 1 | 2011 | 585 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 1999 | 1917 | 0.020 |
Why?
|
Inflammation | 1 | 2006 | 10716 | 0.020 |
Why?
|
Kinetics | 2 | 1998 | 6371 | 0.020 |
Why?
|
Chemistry | 1 | 1985 | 347 | 0.020 |
Why?
|
Crystallization | 1 | 1986 | 534 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 1985 | 508 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2013 | 1714 | 0.020 |
Why?
|
Immunologic Techniques | 1 | 1985 | 213 | 0.020 |
Why?
|
Antigen-Antibody Reactions | 1 | 2005 | 346 | 0.020 |
Why?
|
Ethanol | 1 | 2011 | 1328 | 0.020 |
Why?
|
Biliopancreatic Diversion | 1 | 2005 | 15 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 1715 | 0.020 |
Why?
|
Drug Resistance, Viral | 1 | 2010 | 849 | 0.020 |
Why?
|
Health Surveys | 2 | 2006 | 4052 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58608 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2304 | 0.020 |
Why?
|
Peptides | 2 | 1987 | 4321 | 0.020 |
Why?
|
MEDLINE | 1 | 2005 | 120 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2014 | 1876 | 0.020 |
Why?
|
Credentialing | 1 | 2005 | 115 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8558 | 0.010 |
Why?
|
Liposomes | 1 | 1988 | 774 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1985 | 1142 | 0.010 |
Why?
|
Peptide Library | 1 | 2005 | 347 | 0.010 |
Why?
|
Cytokines | 1 | 1999 | 7261 | 0.010 |
Why?
|
Signal Transduction | 1 | 2007 | 23254 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1987 | 1338 | 0.010 |
Why?
|
Patient Preference | 1 | 2011 | 908 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3584 | 0.010 |
Why?
|
Phytosterols | 1 | 2003 | 54 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2479 | 0.010 |
Why?
|
Soybean Proteins | 1 | 2003 | 55 | 0.010 |
Why?
|
Tryptophan | 1 | 1985 | 484 | 0.010 |
Why?
|
Disulfides | 1 | 1985 | 464 | 0.010 |
Why?
|
Oligosaccharides | 1 | 1985 | 403 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2936 | 0.010 |
Why?
|
Remission Induction | 1 | 2009 | 2390 | 0.010 |
Why?
|
Systole | 1 | 2005 | 948 | 0.010 |
Why?
|
Gastroplasty | 1 | 2005 | 156 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15773 | 0.010 |
Why?
|
Psychometrics | 1 | 2012 | 3034 | 0.010 |
Why?
|
Arginine | 1 | 1985 | 934 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 1987 | 1152 | 0.010 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2005 | 496 | 0.010 |
Why?
|
Ligands | 1 | 1989 | 3288 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 1987 | 1461 | 0.010 |
Why?
|
Protein Conformation | 2 | 1988 | 3966 | 0.010 |
Why?
|
Mutation | 2 | 1996 | 29764 | 0.010 |
Why?
|
Biological Evolution | 1 | 1987 | 1067 | 0.010 |
Why?
|
Nuts | 1 | 2003 | 262 | 0.010 |
Why?
|
Glucose Intolerance | 1 | 2005 | 578 | 0.010 |
Why?
|
Tyrosine | 1 | 1985 | 1440 | 0.010 |
Why?
|
Endocytosis | 1 | 2005 | 964 | 0.010 |
Why?
|
Lysine | 1 | 1985 | 992 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36181 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2011 | 1417 | 0.010 |
Why?
|
Models, Molecular | 2 | 1988 | 5413 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 2004 | 664 | 0.010 |
Why?
|
Binding Sites | 1 | 1989 | 6038 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1985 | 3087 | 0.010 |
Why?
|
Population Surveillance | 1 | 2010 | 2608 | 0.010 |
Why?
|
Aging | 1 | 1998 | 8595 | 0.010 |
Why?
|
Appetite Stimulants | 1 | 1998 | 14 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12482 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6190 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15669 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1987 | 6118 | 0.010 |
Why?
|
Prognosis | 2 | 2012 | 29463 | 0.010 |
Why?
|
Appetite Depressants | 1 | 1998 | 109 | 0.010 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1999 | 375 | 0.010 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1999 | 283 | 0.010 |
Why?
|
Glucagon-Like Peptides | 1 | 1998 | 151 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1999 | 629 | 0.010 |
Why?
|
Decision Making | 1 | 2011 | 3901 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12503 | 0.010 |
Why?
|
HLA-A2 Antigen | 2 | 1987 | 212 | 0.010 |
Why?
|
E-Selectin | 1 | 1999 | 575 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10806 | 0.010 |
Why?
|
Medical Errors | 1 | 2005 | 1253 | 0.010 |
Why?
|
Protein Binding | 1 | 1989 | 9300 | 0.010 |
Why?
|
Gastric Bypass | 1 | 2005 | 818 | 0.010 |
Why?
|
Genomic Library | 1 | 1996 | 189 | 0.010 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 1998 | 364 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14393 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1999 | 1250 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1126 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4048 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 2631 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1996 | 1544 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1996 | 775 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8312 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1996 | 781 | 0.010 |
Why?
|
Drug Interactions | 1 | 1998 | 1419 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2005 | 1916 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13432 | 0.010 |
Why?
|
RNA, Messenger | 2 | 1999 | 12755 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2008 | 8976 | 0.010 |
Why?
|
Leukocytes | 1 | 1999 | 2030 | 0.010 |
Why?
|
Fatty Acids | 1 | 1998 | 1803 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1987 | 10059 | 0.010 |
Why?
|
Immunotherapy | 1 | 2005 | 4610 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10382 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16782 | 0.000 |
Why?
|
Antigens, CD | 1 | 1999 | 3909 | 0.000 |
Why?
|
Phosphatidylethanolamines | 1 | 1988 | 129 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1999 | 4342 | 0.000 |
Why?
|
Endopeptidase K | 1 | 1987 | 23 | 0.000 |
Why?
|
Chymotrypsin | 1 | 1987 | 138 | 0.000 |
Why?
|
Biopsy | 1 | 1999 | 6760 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6067 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1996 | 4284 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1999 | 11025 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1988 | 2560 | 0.000 |
Why?
|
Clone Cells | 1 | 1987 | 1652 | 0.000 |
Why?
|
Macrophages | 1 | 1999 | 5702 | 0.000 |
Why?
|
Endopeptidases | 1 | 1987 | 772 | 0.000 |
Why?
|
DNA | 1 | 1996 | 7222 | 0.000 |
Why?
|